| (Values in U.S. Thousands) | Jun, 2014 | Jun, 2013 | Jun, 2012 | Dec, 2017 | Sep, 2017 |
| Sales | 175,090 | 151,790 | 137,370 | 0 | 0 |
| Sales Growth | +15.35% | +10.50% | unch | unch | unch |
| Net Income | 21,890 | 19,120 | 9,650 | 0 | 0 |
| Net Income Growth | +14.49% | +98.13% | unch | unch | unch |
Bohai Pharmaceutical (BOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Bohai Pharmaceuticals Group, Inc. operates as a manufacturer and distributor of herbal pharmaceuticals based on Traditional Chinese Medicine in China. Its lead products include Tongbi Capsules, Tongbi Tablets and Lung Nourishing Cream. The Company produces medicines for treatment of common health problems such as rheumatoid arthritis, viral infections, gynecological diseases, cardio vascular issues and respiratory diseases. Bohai Pharmaceuticals Group, Inc. is headquartered in Yantai, China.
Fiscal Year End Date: 06/30